• Mi Re-Unir
    Búsqueda Avanzada
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Ver ítem 
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem

    Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

    Autor: 
    Ramos-Rincón, José-Manuel
    ;
    Pinargote-Celorio, Héctor
    ;
    de Mendoza, Carmen
    ;
    Ramos-Belinchón, Clara
    ;
    Barreiro, Pablo
    ;
    Gómez-Gallego, Felix
    ;
    Corral, Octavio Jorge
    ;
    Soriano, Vicente
    Fecha: 
    2022
    Palabra clave: 
    antiviral therapy; cirrhosis; hepatitis C; HIV; hospitalizations; liver cancer; JCR; Scopus
    Revista / editorial: 
    Journal of Viral Hepatitis
    Citación: 
    Ramos‐Rincon, J. M., Pinargote‐Celorio, H., de Mendoza, C., Ramos‐Belinchón, C., Barreiro, P., Gómez‐Gallego, F., ... & Soriano, V. (2022). Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies. Journal of viral hepatitis, 29(9), 777-784.
    Tipo de Ítem: 
    Articulo Revista Indexada
    URI: 
    https://reunir.unir.net/handle/123456789/14220
    DOI: 
    https://doi.org/10.1111/jvh.13708
    Dirección web: 
    https://onlinelibrary.wiley.com/doi/10.1111/jvh.13708
    Open Access
    Resumen:
    Chronic hepatitis C virus (HCV) infection is major cause of decompensated cirrhosis and liver cancer. The advent of curative new antiviral therapies since year 2015 has dramatically improved the prognosis of HCV patients. The real-life clinical benefits at country level of these therapies have not yet been assessed. This is a retrospective study of all hospitalizations in Spain including HCV as diagnosis using the Spanish National Registry of Hospital Discharges. Information was retrieved from 1997 to 2019. From 81,482,509 nationwide hospital admissions recorded during the study period, 1,057,582 (1.29%) included HCV as diagnosis. The median age of HCV hospitalized patients was 54 years old. Males accounted for 63.2% of cases. Most HCV admissions recorded chronic hepatitis C whereas acute hepatitis C was reported in less than 3%. In-hospital death occurred in 6.4% of HCV admissions. Coinfection with HIV or hepatitis B virus was seen in 14.8% and 6.4%, respectively. Patients hospitalized with HIV-HCV coinfection represented 14.8% of cases and were on average 17 years younger than HCV-monoinfected individuals. The rate of HCV hospitalizations significantly increased until 2005, and then stabilized for one decade. A significant reduction was noticed since 2015. However, whereas the proportion of HCV-associated hepatic decompensation events declined since then, liver cancer diagnoses increased. In conclusion, hospital admissions of HCV individuals significantly declined in Spain since 2015 following a wide prescription of new oral direct-acting antivirals. This reduction was primarily driven by a fall of hepatic decompensation events whereas HCV-related liver cancer continues rising.
    Mostrar el registro completo del ítem
    Ficheros en el ítem
    icon
    Nombre: hepatitis_C_hospitalizations_Spain.pdf
    Tamaño: 706.3Kb
    Formato: application/pdf
    Ver/Abrir
    Este ítem aparece en la(s) siguiente(s) colección(es)
    • Artículos Científicos WOS y SCOPUS

    Estadísticas de uso

    Año
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    Vistas
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    53
    87
    56
    Descargas
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    86
    115
    68

    Ítems relacionados

    Mostrando ítems relacionados por Título, autor o materia.

    • Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (Hepatology International, 2022)
      Background: Chronic viral hepatitis B, C, and D are the main causes of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented more than 2 decades ago in most EU countries. Furthermore, ...
    • Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (Alimentary Pharmacology and Therapeutics, 2023)
      Background: Chronic hepatitis B virus (HBV) infection is a major cause of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented in Spain two decades ago, and potent oral antivirals ...
    • Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Moreno-Torres, Víctor; Treviño, Ana; Barreiro, Pablo; Corral, Octavio Jorge; Soriano, Vicente (Journal of Clinical Virology, 2023)
      Background: Before the advent of COVID-19 vaccines, hospitalizations due to SARS-CoV-2 infection during 2020 collapsed most medical centers worldwide. Disruptions in health care for clinical conditions other than COVID-19 ...

    Mi cuenta

    AccederRegistrar

    ¿necesitas ayuda?

    Manual de UsuarioContacto: reunir@unir.net

    Listar

    todo Re-UnirComunidades y coleccionesPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de accesoEsta colecciónPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de acceso






    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja
     
    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja